Impact of <i>CYP2D6*10</i> on recurrence‐free survival in breast cancer patients receiving adjuvant tamoxifen therapyKazuma Kiyotani, Hitoshi Zembutsu, Michiaki Kubo et al.|Cancer Science|2008Cited by 181
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen responseKazuma Kiyotani, Hitoshi Zembutsu, Taisei Mushiroda et al.|Pharmacogenetics and Genomics|2010Cited by 42
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administrationTaeko Nagao, Mitsunori Sasa, Yusuke Nakamura et al.|World Journal of Surgical Oncology|2009Cited by 14